C-Peptide Area Under the Curve at Glucagon Stimulation Test Predicts Glucose Improvements by GLP-1 Receptor Analogue: A Retrospective Observational Study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-6961
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
C-Peptide Area Under the Curve at Glucagon Stimulation Test Predicts Glucose Improvements by GLP-1 Receptor Analogue: A Retrospective Observational Study ; day:20 ; month:2 ; year:2019 ; pages:1-9
Diabetes therapy ; (20.2.2019), 1-9
- Urheber
-
Ohbatake, Azusa
Yagi, Kunimasa
Karashima, Shigehiro
Shima, Yuki
Miyamoto, Yukiko
Asaka, Hiroyuki
Okazaki, Satoko
Kometani, Mitsuhiro
Kawashiri, Masa-aki
Takeda, Yoshiyu
Yoneda, Takashi
Chujo, Daisuke
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13300-019-0586-6
- URN
-
urn:nbn:de:101:1-2019032014371340593047
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ohbatake, Azusa
- Yagi, Kunimasa
- Karashima, Shigehiro
- Shima, Yuki
- Miyamoto, Yukiko
- Asaka, Hiroyuki
- Okazaki, Satoko
- Kometani, Mitsuhiro
- Kawashiri, Masa-aki
- Takeda, Yoshiyu
- Yoneda, Takashi
- Chujo, Daisuke
- SpringerLink (Online service)
Ähnliche Objekte (12)
Vasodilator Effect of Glucagon: Receptorial Crosstalk Among Glucagon, GLP-1, and Receptor for Glucagon and GLP-1
Glucagon-like peptide 1 (GLP-1)
GLP-1/glucagon receptor co-agonism for treatment of obesity
Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies
Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
GLP-1 metabolite GLP-1(9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes
Peptide-oligourea hybrids analogue of GLP-1 with improved action in vivo
Correction to: Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies
Improvements and Application of the STatistical Analogue Resampling Scheme STARS
Vasodilator Effect of Glucagon: Receptorial Crosstalk Among Glucagon, GLP-1, and Receptor for Glucagon and GLP-1
Glucagon-like peptide 1 (GLP-1)
GLP-1/glucagon receptor co-agonism for treatment of obesity
Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies
Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
GLP-1 metabolite GLP-1(9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes
Peptide-oligourea hybrids analogue of GLP-1 with improved action in vivo
Correction to: Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies
Improvements and Application of the STatistical Analogue Resampling Scheme STARS
Vasodilator Effect of Glucagon: Receptorial Crosstalk Among Glucagon, GLP-1, and Receptor for Glucagon and GLP-1
Glucagon-like peptide 1 (GLP-1)
GLP-1/glucagon receptor co-agonism for treatment of obesity
Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies
Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
GLP-1 metabolite GLP-1(9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes
Peptide-oligourea hybrids analogue of GLP-1 with improved action in vivo
Correction to: Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies